13567_2019_631_MOESM1_ESM.docx (87.37 kB)
0/0

MOESM1 of Development of a recombinant Newcastle disease virus-vectored vaccine for infectious bronchitis virus variant strains circulating in Egypt

Download (87.37 kB)
journal contribution
posted on 11.02.2019 by Hassanein Abozeid, Anandan Paldurai, Berin Varghese, Sunil Khattar, Manal Afifi, Sahar Zouelfakkar, Ayman El-Deeb, Magdy El-Kady, Siba Samal
Additional file 1. Cloning of three different forms of IBV S protein into pUC57. (A) Chicken-codon-optimized wild type IBV S gene cloned into pUC57 (pUC57-CO.S). IBV S protein domains: ectodomain, transmembrane (TM) and cytoplasmic tail are represented in blue boxes, preceded by NDV gene-end (GE, in Red), intergenic (IGS, in black), gene-start (GS, in green) and Kozak (in white) sequences, and flanked by PmeI sites. Dotted numbers indicate amino acid positions in the cytoplasmic tail of IBV S protein. Arrows with circled numbers indicate the primers used to induce the S protein modifications using pUC57-CO.S as template (refer Table 1 for the primers). (B) Primers 1, 2, 3 and 4 used to induce the “Y1145A” mutation and add the last 12 aa of the cytoplasmic tail of NDV F protein (Fct12, represented in grey box) to create pUC57-CO.S(Y1145A)+Fct12 (C) Primers 1 and 5 used to replace the cytoplasmic tail of IBV S protein by the last 12 aa of the cytoplasmic tail of NDV F protein to create pUC57-CO.SΔct+Fct12.

Funding

Cultural Affairs and Missions Sector, Ministry of Higher Education (EG)

History

Exports